Population Pharmacokinetics of Terbinafine in Children With Tinea Capitis

Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.

1. 1This trial is focused on measuring how terbinafine moves through children's bodies rather than testing whether it works — does that mean my child would be receiving a treatment that's already used for tinea capitis, and what would the blood sampling schedule actually look like for them?
2. 2Since this study is measuring drug concentration and how quickly the body clears terbinafine, would my child need extra blood draws beyond what's typical for standard treatment, and how many times would we need to come in?
3. 3The trial is listed as 'Phase NA,' which suggests it's a pharmacokinetics study rather than a traditional drug efficacy trial — does that mean the researchers are trying to figure out the right dosing for children specifically, and is the current dosing my child would receive already considered safe?
4. 4Would my child receive the same terbinafine treatment they'd get outside of this trial, or are there differences in how it's given, and could we discuss whether standard care outside the study might be just as good an option for treating their tinea capitis?
5. 5Because this study is collecting data on how terbinafine is processed in children's bodies, what happens if the drug levels measured in my child turn out to be outside the expected range — would their dose be adjusted during the study?

Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.